Ballard, Clive

Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study

Ballard, C., Sauter, M., Scheltens, P., He, Y., Barkhof, F., van Straaten, E. C. W., van der Flier, W. M., Hsu, C., Wu, S., & Lane, R. (2008) · Current Medical Research and Opinion

Dementia and Cognitive Impairment ResearchCholinesterase and Neurodegenerative Diseases

Cited by 147

Management of Neuropsychiatric Symptoms in People with Dementia

Ballard, C., & Corbett, A. (2010) · CNS Drugs

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 147

Trial of pimavanserin in dementia-related psychosis

Tariot, P. N., Cummings, J. L., Soto-Martin, M. E., Ballard, C., Erten-Lyons, D., Sultzer, D. L., Devanand, D. P., Weintraub, D., McEvoy, B., Youakim, J. M., et al. (2021) · New England Journal of Medicine

Schizophrenia research and treatmentDementia and Cognitive Impairment Research

Cited by 145

Impact of antipsychotic review and nonpharmacological intervention on antipsychotic use, neuropsychiatric symptoms, and mortality in people with dementia living in nursing homes: a factorial cluster-randomized controlled trial by the well-being and health for people with dementia (WHELD) program

Ballard, C., Orrell, M., YongZhong, S., Moniz-Cook, E., Stafford, J., Whittaker, R., Woods, B., Corbett, A., Garrod, L., Khan, Z., et al. (2016) · American Journal of Psychiatry

Dementia and Cognitive Impairment ResearchGeriatric Care and Nursing Homes

Cited by 142

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer’s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial.

Burns, D. K., Alexander, R. C., Welsh-Bohmer, K. A., Culp, M., Chiang, C., O’Neil, J., Evans, R. M., Harrigan, P., Plassman, B. L., Burke, J. R., et al. (2021) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 130

Associations between cognitively stimulating leisure activities, cognitive function and age‐related cognitive decline

Ferreira, N., Owen, A., Mohan, A., Corbett, A., & Ballard, C. (2015) · International Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchCognitive Abilities and Testing

Cited by 101

Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study

Vik‐Mo, A. O., Giil, L. M., Ballard, C., & Aarsland, D. (2018) · International Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 99

Systematic review of services providing information and/or advice to people with dementia and/or their caregivers

Corbett, A., Stevens, J., Aarsland, D., Day, S., Moniz‐Cook, E., Woods, R., Brooker, D., & Ballard, C. (2012) · International Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchNursing care and research

Cited by 87

Adverse effects of Z-drugs for sleep disturbance in people living with dementia: a population-based cohort study

Richardson, K., Loke, Y. K., Fox, C., Maidment, I., Howard, R., Steel, N., Arthur, A., Boyd, P. J., Aldus, C., Ballard, C., et al. (2020) · BMC Medicine

Pharmaceutical Practices and Patient OutcomesSleep and related disorders

Cited by 73

Evaluation of liraglutide in the treatment of Alzheimer's disease

Edison, P., Femminella, G. D., Ritchie, C. W., Holmes, C., Walker, Z., Ridha, B. H., Raza, S., Livingston, N. R., Nowell, J., Busza, G., et al. (2021) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 73

Synaptic proteins in CSF relate to Parkinson’s disease stage markers

Bereczki, E., Bogstedt, A., Höglund, K., Tsitsi, P., Brodin, L., Ballard, C., Svenningsson, P., & Aarsland, D. (2017) · npj Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research

Cited by 72

Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease

Skogseth, R., Mulugeta, E., Ballard, C., Rongve, A., Nore, S., Alves, G., & Aarsland, D. (2008) · Dementia and Geriatric Cognitive Disorders

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 71

Continuity of GP care for patients with dementia: Impact on prescribing and the health of patients

Delgado, J., Evans, P. H., Gray, D. P., Sidaway-Lee, K., Allan, L., Clare, L., Ballard, C., Masoli, J., Valderas, J. M., & Melzer, D. (2022) · British Journal of General Practice

Pharmaceutical Practices and Patient OutcomesPrimary Care and Health Outcomes

Cited by 70

Postmortem Cortical Transcriptomics of Lewy Body Dementia Reveal Mitochondrial Dysfunction and Lack of Neuroinflammation

Rajkumar, A. P., Bidkhori, G., Shoaie, S., Clarke, E., Morrin, H., Hye, A., Williams, G., Ballard, C., Francis, P., & Aarsland, D. (2020) · The American Journal of Geriatric Psychiatry

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 65

Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease

DeMichele-Sweet, M. A. A., Klei, L., Creese, B., Harwood, J. C., Weamer, E. A., McClain, L., Sims, R., Hernandez, I., Moreno-Grau, S., Tárraga, L., et al. (2021) · Molecular Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 64

Mental health of people living with dementia in care homes during COVID-19 pandemic

Velayudhan, L., Aarsland, D., & Ballard, C. (2020) · International Psychogeriatrics

Geriatric Care and Nursing HomesCOVID-19 and Mental Health

Cited by 62

Online assessment of risk factors for dementia and cognitive function in healthy adults

Huntley, J., Corbett, A., Wesnes, K., Brooker, H., Stenton, R., Hampshire, A., & Ballard, C. (2018) · International Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchCognitive Abilities and Testing

Cited by 58

CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies

Mulugeta, E., Londos, E., Ballard, C., Alves, G., Zetterberg, H., Blennow, K., Skogseth, R., Minthon, L., & Aarsland, D. (2011) · Journal of Neurology, Neurosurgery & Psychiatry

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 54

Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome

Mok, K. Y., Jones, E. L., Hanney, M., Harold, D., Sims, R., Williams, J., Ballard, C., & Hardy, J. (2014) · Neurobiology of Aging

Alzheimer's disease research and treatmentsDown syndrome and intellectual disability research

Cited by 48

The prevalence of depression in the carers of dementia sufferers

Coope, B., Ballard, C., Saad, K., Patel, A., Bentham, P., Bannister, C., Graham, C., & Wilcock, G. (1995) · International Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchFamily Caregiving in Mental Illness

Cited by 48

Evidence that PICALM affects age at onset of Alzheimer's dementia in Down syndrome

Jones, E. L., Mok, K., Hanney, M., Harold, D., Sims, R., Williams, J., & Ballard, C. (2013) · Neurobiology of Aging

Down syndrome and intellectual disability researchAlzheimer's disease research and treatments

Cited by 47

Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology

O’Brien, J., Thomas, A., Ballard, C., Brown, A., Ferrier, N., Jaros, E., & Perry, R. (2001) · Biological Psychiatry

Dementia and Cognitive Impairment ResearchTreatment of Major Depression

Cited by 46

Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry

Enache, D., Fereshtehnejad, S. ‐., Kåreholt, I., Cermakova, P., Garcia‐Ptacek, S., Johnell, K., Religa, D., Jelic, V., Winblad, B., Ballard, C., et al. (2016) · Acta Psychiatrica Scandinavica

Dementia and Cognitive Impairment ResearchPharmaceutical Practices and Patient Outcomes

Cited by 42

Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms

Ballard, C., Youakim, J. M., Coate, B., & Stankovic, S. (2019) · The Journal of Prevention of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 40